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Tumor necrosis factor-a (TNF) is considered to be a key lethality [5 -7] . Similarly, anti-TNF did not influence coagulation activation during nonlethal endotoxemia in chimpanzees mediator in the pathogenesis of sepsis syndrome. TNF is released into the circulation early after intravenous bacterial chal- [8] . By contrast, anti-TNF completely prevented the fibrinolytic response to nonlethal endotoxemia [8] , whereas in the lethal lenges in animals, and neutralization of endogenous TNF prevents lethality in these acute models [1] . The role of TNF models fibrinolysis was not investigated. Recently, the capacity of a 55-kDa TNF receptor -IgG fusion in disturbances of the hemostatic mechanism during systemic infection is less clear. Sepsis-or endotoxin-induced activation protein (TNFR55:IgG) to effectively neutralize TNF activity and to strongly reduce lethality in baboons infused with a lethal of the coagulation system is driven by the tissue factor -mediated extrinsic pathway [2] . TNF potently up-regulates tissue dose of live Escherichia coli was reported [9] . Interestingly, treatment with TNFR55:IgG attenuated fibrinogen consumpfactor expression on endothelial and mononuclear cells, suggesting a role for this cytokine in coagulation activation [1, tion and the increases in prothrombin and partial thromboplastin times caused by the bacteremia. These findings prompted 2]. In accord, intravenous injection of recombinant TNF into humans or baboons induced activation of the common pathway us to study in more detail the effect of TNFR:IgG on the activation of coagulation and fibrinolysis. of the coagulation system [3, 4] . However, treatment of baboons with severe bacteremia or endotoxemia with a neutralizing anti-TNF monoclonal antibody did not result in a noticeable Methods effect on activation of the coagulation system, in spite of the fact that such treatment afforded significant protection against Study design. The present study was performed simultaneously with a previously reported investigation [9] . Details of the animal study have been reported elsewhere [9] . Briefly, baboons (Papio anubis) (10-14 kg) were challenged with E. coli with or without Assays. All assays were performed in heparinized plasma samples and were described in detail previously [4, 10] . Coagulation activation was determined by measuring thrombin-antithrombin III (TAT) complexes by ELISA. Fibrinolytic activation was monitored by measurements of tissue type plasminogen activator (tPA) by ELISA, plasminogen activator inhibitor type I (PAI-1) by ELISA, and plasmin-a 2 -antiplasmin (PAP) complexes by RIA. Levels of PAP complexes are expressed as percentage of the level present in normal baboon plasma in which a maximal amount of PAP complexes was generated by a 1-h incubation with an equal volume of urokinase (50 mg/mL) in the presence of 0.4 M methylamine. Neutrophil degranulation was determined by measurement of the plasma concentrations of elastase-a 1 -antitrypsin complexes by RIA. Secretory phospholipase A 2 (sPLA 2 ) was measured with an ELISA.
Statistical analysis. All values are expressed as mean { SE. Differences within groups were tested by repeated-measures analysis of variance. Differences between groups were tested by repeated-measures analysis of variance (interaction between treatment and time). P values are therefore derived from analyses in which data from all time points were included. P õ .05 was considered to represent a significant difference.
Results
In the previously reported study, treatment with TNFR55:IgG had been found to completely neutralize TNF activity throughout the observation period and to significantly attenuate the severe hypotensive response and lethality observed in the animals infused with E. coli [9] . Three of four baboons pretreated with placebo had died, after 6, 30, and 36 h, respectively, while all baboons treated with TNFR55:IgG survived.
The infusion of E. coli was associated with a strong activation of the common pathway of the coagulation system, as reflected by a sustained rise in the plasma concentrations of TAT complexes, peaking after 6 h (959 { 296 ng/mL; P õ .05 vs. time) (figure 1). This coagulation response was significantly blunted by treatment with TNFR55:IgG. Peak levels of TAT complexes in TNFR55:IgG-treated animals were 322 { 90 ng/mL (P õ .05 vs. placebo). Bacteremia also induced a marked activation of the fibrinolytic system, as indicated by increases in the plasma concentrations of tPA (peak of 12.9 { 2.2 ng/mL after 8 h; P õ .05 vs. time), PAI-1 (peak of 3669 { 1298 ng/mL after 8 h; P õ .05), and PAP complexes (peak of 0.68% { 0.32% after 4 h; P õ .05) (figure 1). Treatment with TNFR55:IgG had no influence on the rise in tPA levels but significantly attenuated the release of PAI-1 during bacteremia. Peak PAI-1 levels in TNFR55:IgG-infused baboons were 1095 { 314 ng/mL (P õ .05 vs. placebo). The plasma concentrations activator inhibitor type I (PAI-1), and plasmin-a 2 -antiplasmin (PAP) complexes after infusion of Escherichia coli in baboons pretreated with either As reported earlier [9] , bacteremia was associated with a TNFR55:IgG (n Å 4, l) or placebo (n Å 4, ᭺). P indicates difference sustained neutrocytopenia, which was partially reversed by between groups by analysis of variance. NS Å nonsignificant.
protein results in an attenuated procoagulant response, as reflected by inhibition of release of TAT complexes, in the absence of an effect on activation of fibrinolysis. This result is in line with the previously reported inhibition of more rough measures of coagulation activation, such as fibrinogen consumption and prolongation of prothrombin and partial thromboplastin times [9] . However, it should be noted that, thus far, studies in which endogenous TNF was neutralized in primates with either lethal or sublethal bacteremia or endotoxemia did not reveal any effect on activation of the coagulation system [5 -8] , while anti-TNF did abrogate the fibrinolytic response to low-dose endotoxin in chimpanzees [8] . We do not have an explanation for the apparent discrepancy of the present results with those from earlier studies, other than that the compound used to neutralize TNF activity, a dimeric 55-kDa TNF receptor -IgG fusion protein (which also has affinity for lymphotoxin), was different.
We consider it unlikely that our results are influenced by less-than-complete neutralization of TNF. Plasma TNF activity remained completely neutralized (as determined by the highly sensitive WEHI cytotoxicity assay) in animals treated with TNFR55:IgG throughout the entire observation period [9] . In fact, even lower doses of TNFR55:IgG than used in this study were able to completely neutralize TNF activity [9] . Further, TNFR55:IgG has been found to form stable complexes with TNF, in which aspect it differs from a similar IgG fusion protein containing a dimeric p75 TNF receptor [11] . Further, any rise in tPA and PAP complexes [8, 12] , while in the present study, the levels of PAP complexes even tended to be higher in animals in which TNF was effectively neutralized. TNFR55:IgG. Infusion of E. coli also resulted in degranulation Excessive activation of neutrophils may contribute in an of neutrophilic granulocytes, as reflected by an increase in the important way to tissue injury in sepsis [13] . The plasma conplasma levels of elastase -a 1 -antitrypsin complexes, maximal centrations of elastase -a 1 -antitrypsin complexes have been levels being measured at the end of the study period at 8 h used as indicators of neutrophil degranulation in vivo and corre-(1234 { 153 ng/mL; P õ .05 vs. time) (figure 2). TNFR55:IgG late with mortality rates in patients with sepsis [13] . TNF has significantly inhibited this response, with elastase -a 1 -antitrypbeen found to trigger neutrophil degranulation in vitro [1] and sin complexes reaching an approximately constant level at in humans and baboons in vivo [4, 14] . The present results Ç500 ng/mL from 1 to 8 h (P õ .05 vs. placebo). E. coli that TNFR55:IgG reduced the release of elastase in bacteremic bacteremia further caused a rise in the plasma concentrations baboons are in line with a similar inhibition of elastase release of sPLA 2 , the highest levels being measured at the end of the by an anti-TNF antibody in endotoxemic chimpanzees [8] and observation period (8 h: 4217 { 2081 ng/mL; P õ .05 vs.
therefore extend the role of TNF in neutrophil degranulation time) (figure 2). Although TNFR55:IgG reduced sPLA 2 release to lethal bacteremia. (8 h: 1845 { 1284 ng/mL), the difference with control baboons sPLA 2 is a regulatory enzyme controlling the synthesis of did not reach statistical significance because of a large interindieicosanoids and platelet-activating factor, which has been imvidual variation.
plicated in the pathogenesis of tissue injury associated with sepsis. Injection of TNF into baboons elicited a rapid release of sPLA 2 [4] . Pretreatment with TNFR55:IgG was associated Discussion with a modest, nonsignificant inhibition of sPLA 2 release, suggesting that TNF is not a critical mediator of this response in The main finding of this study is that pretreatment of baboons with severe E. coli bacteremia with a TNF receptor -IgG fusion sepsis. Similarly, infusion of an anti-TNF antibody also mod-/ 9d2b$$jy42 05-28-97 07:49:24 jinfal UC: J Infect
Aspergillus fumigatus is a pathogen causing diverse respiratory disorders. Several studies have suggested that fungal proteases may play a role in the pathogenicity of fungi. Since the airways are the most common route for entry of A. fumigatus, this study focused on the ability of fungal proteases to induce the release of proinflammatory cytokines and to cause cell detachment in human pulmonary epithelial cell lines. It was shown that fungal serine protease activity induced the production of interleukin (IL)-8 and IL-6 and monocyte chemotactic protein-1 and caused cell detachment in a dose-dependent fashion. Chymostatin, antipain, phenylmethylsulfonyl fluoride, and heat treatment completely inhibited fungal protease activity, cytokine production and cell detachment; antileukoprotease partially inhibited these activities. By causing cell detachment, fungal proteases may decrease the physical barrier function of the epithelium; however, by eliciting a cytokine response, the epithelium may signal the mucosal inflammatory response against A. fumigatus.
performed as described elsewhere [7] .
Heat treatment of E-ColCF
Aspergillus fumigatus is a fungal pathogen of major clinical was performed at 65ЊC for 30 min.
importance that predominantly affects the respiratory system
Quantification of fungal protease activity and inhibition of en-
and may infiltrate the bronchial mucosa [1, 2] . The virulence zyme activity. Elastase activity was quantified using the elastaseof A. fumigatus is due to specific properties by which it is able specific substrate N-succinyl-alanyl-alanyl-prolyl-leucine p-nitroto bypass the cellular and humoral defenses of the host, and anilide (Sigma, St. Louis). Substrate (final concentration, 2.5 mM) the production of extracellular proteases has been implicated was added to E-ColCF (final concentration, 0.33 mg protein/mL) as an important factor in its pathogenicity [3 -5] . Although A. including microorganisms. In addition, the epithelium may play Total protease and gelatinase activities were measured according a paramount role in the orchestration of the local immune to the methods described elsewhere [7] using casein (Merck, Darmresponse by releasing inflammatory products and expressing stadt, Germany) and orange gelatin (BIOK, Vilnius, Lithuania) as various types of cell adhesion molecules (reviewed in [6] ). The substrates, respectively. One unit of enzyme activity is the amount present study focuses on the production of proinflammatory of enzyme that hydrolyses 1 mg of casein (total protease activity) cytokines and the induction of cell detachment in two pulmo- or E-ColCF concentrations. In NCI-H292 cells, however, there (Sigma) [8] .
was a 65% decrease in MTT reduction with 200 mg/mL E- Inhibition of fungal protease activity by the serine protease inhibitorschymostatin,antipain,PMSF,andrALP. Quantification of the protease activities in E-ColCF revealed 7.4, 11.2, Results and 3.3 U/mg protein for elastase, gelatinase, and total protease activities, respectively (data not shown). Chymostatin (an inCytokine production by bronchial and alveolar epithelial cells after incubation with fungal culture filtrates. E-ColCF hibitor of chymotrypsin-like serine protease activity) completely abolished elastase and gelatinase activities and largely caused a dose-dependent increase in IL-8 production by A549 cells that was significant at concentrations of §0.32 mg/mL inhibited total protease activity (75.8%). Comparable results were obtained with the serine protease inhibitors antipain and E-ColCF (figure 1B). At 1.6 mg/mL E-ColCF, the IL-8 levels reached maximum, and cell detachment became evident (fig-PMSF (data not shown). With 40 mM rALP (an endogenous serine protease inhibitor), the activities for elastase, gelatinase, ure 1B). With E-ColCF concentrations ú1.6 mg/mL, IL-8 production steadily decreased but remained elevated over that and total protease were inhibited by 68.9%, 31.3%, and 15.2%, respectively. Heat treatment of E-ColCF completely abolished of the negative control (figure 1). Comparable results were found for the production of IL-6 by A549 cells; however, ILall enzyme activities (data not shown). Inhibition of cytokine production by protease inhibitors and 6 production was optimal at 8 mg/mL E-ColCF (data not shown). MCP-1 production by A549 cells (figure 1B) paralheat treatment of E-ColCF. Heat treatment or addition of chymostatin, antipain, or PMSF to E-ColCF blocked its ability leled the dose-response curve for the production of IL-8 in this cell line. MCP-1 levels were significantly increased beto induce IL-8 production in A549 cells at 1 mg/mL (table 1) . Identical results were found for the production of MCP-1 and tween 0.32 and 8.0 mg/mL E-ColCF (P õ .004), with a maximum at 1.6 mg/mL E-ColCF. In NCI-H292 cells, IL-6 produc-IL-6 (data not shown). In NCI-H292 cultures, the increase in IL-8 production with 40 mg/mL E-ColCF was partially inhibtion was significantly increased at 0.32 mg/mL E-ColCF (P õ .008), with an optimum at 1.6 mg/mL E-ColCF ( figure 1A) .
ited by chymostatin (69.0%), antipain (71.9%), and PMSF (74.3%) and largely inhibited by heat treatment of E-ColCF At 200 mg/mL E-ColCF, the IL-6 response was significantly lower than that of the negative control (P õ .004). The dose-(85.4%; table 1). Cell detachment was completely inhibited by the serine protease inhibitors and heat treatment of the E-ColCF response curve for IL-8 was markedly different from that for IL-6 in this cell line; an increase in IL-8 production was found (table 1) . rALP partially inhibited the E-ColCF -induced IL-8 production (64.7%) and cell detachment in NCI-H292 cells at 1.6 mg/mL E-ColCF (P õ .04; figure 1A) (data not shown). Control experiments showed that the inhibi-8 are prototype members of the C-C and C-X-C families of chemokines and act as potent chemoattractants and activators tors had no effect on spontaneous and IL-1a -or PMA-induced cytokine production or on viability and metabolic activity of of monocytes, lymphocytes, and neutrophils, respectively [9, cells from either cell line. Viability was always ú95% (data 10]. Production of these chemokines in vivo may, therefore, not shown).
provide a set of signals responsible for activating a broad spectrum of cellular host defense involving monocytes, lymphocytes, and neutrophils.
Discussion
The observed decrease in cytokine production at higher EColCF concentrations is remarkable. The decrease in cytokine In this study, we showed that culture filtrates from A. fumigaproduction by the A549 cells coincided with cell detachment tus induced the production of proinflammatory cytokines and without affecting cell viability or metabolic activity. In NCIcaused cell detachment in pulmonary epithelial cell lines. Both H292 cells, however, cell detachment coincided with a 65% phenomena were inhibited by the inhibition of fungal serine reduction in metabolic activity, but in these cells the IL-8 proprotease activity, suggesting that serine proteases released from duction (in contrast to the IL-6 production) continued to in-A. fumigatus mediate these effects.
crease with higher E-ColCF concentrations. Since the immunoThe production of MCP-1 and IL-8 by the epithelial cells may important for inflammatory processes. MCP-1 and ILreactivities of IL-6 and IL-8 were not affected at higher fungal / 9d2b$$jy42 05-28-97 07:49:24 jinfal UC: J Infect protease inhibitors such as ALP may partially inhibit fungal serine protease activity, thereby inhibiting the production of IL-8 production (ng/mL) proinflammatory cytokines by airway epithelial cells. The study village, Ndombo, consists of 3000-4000 inhabitants [1] . This drug is considered to be safe and efficacious. Howand is situated along a main irrigation canal, not far from the town ever, in a Schistosoma mansoni focus in northern Senegal, of Richard-Toll in northern Senegal. The area has been described cure rates after praziquantel treatment were low compared with in detail elsewhere [3] . All study subjects (n Å 138) were residents those in other areas in which S. mansoni is endemic [1, 2] . from this village, and after extensive information about the reThis focus has only recently emerged and is characterized by search and its aims, they volunteered to participate. Each person extremely high intensities of infection [3] . Lack of immunity submitted to a parasitologic examination: 2 stool samples were may also play a role, considering the synergistic action of collected at 2 different days before treatment, and duplicate 25-mg Kato slides were prepared from each sample [6] . The slides praziquantel with host immune responses [4] . However, the were examined 24-72 h after preparation by two microscopists spread of a genetically homogeneous schistosome strain with unaware of the given treatment. Participants were prestratified by low susceptibility to praziquantel cannot be excluded [2, 5] .
age, intensity of infection, and history of previous praziquantel
The aim of the present study was to compare the efficacy of treatment and then randomly allocated to treatment with either 40 praziquantel in this focus with that of another schistosomicidal mg/kg praziquantel (Distocide; Shin Poong, Seoul, Korea) or 20 drug, oxamniquine, in a controlled field trial. mg/kg oxamniquine (Vansil; Pfizer, Groton, CT) by lottery. Pregnant women and children õ5 years old were excluded from the study. Parasitologic examination was repeated at 3 and 6 weeks after treatment. with respect to age, sex, intensity of infection, and history of the chemotherapeutic field trials was a comparison between previous treatment. According to the parasitologic data, subpraziquantel and oxamniquine. Normally, both drugs are jects treated with oxamniquine showed significantly better cure equally effective against S. mansoni; however, if important rates at 6 weeks after treatment than did those who received differences in cure between the two drugs were to be found, praziquantel: 79% versus 36% (P Å .0043; figure 1 ). The reducthey might be caused by regional parasite strain characteristics. tion in egg counts 6 weeks after treatment was higher in the The potential emergence of a parasite strain less susceptible oxamniquine group than in the praziquantel group: 94% versus to praziquantel treatment has been extensively debated [8] . 82% (figure 2).
Although praziquantel resistance has never been reported in other areas in which schistosomiasis is endemic, the epidemic nature of this focus may have caused a homogeneous and Discussion praziquantel-tolerant strain to become apparent. The existence of strain-related variations in tolerance was described for differTreatment with praziquantel normally results in cure rates ent antimonial drugs [9] ; however, this phenomenon was only between 60% and 95% [2] . However, in this focus in northern recently reported for praziquantel by Fallon and Doenhoff [10] . Senegal, treatment with the standard drug regimen of 40 mg/ In a laboratory setting, they were able to select a schistosome kg resulted in a parasitologic cure of only 18% -36%, destrain not susceptible to praziquantel, but this characteristic did pending on the follow-up period after treatment [2, 7] . Various not remain constant when the drug pressure was removed. explanations could be forwarded, such as the very high intensiAdditionally, in the same setting, 1 isolate from the Senegal ties of infection and the recent nature of this focus; however, focus appeared to be more tolerant to praziquantel treatment after several in-depth studies, these possibilities could be re- [5] . We therefore compared praziquantel with oxamniquine in jected (unpublished data). The most important component of a field study, as oxamniquine is considered as effective as praziquantel for community treatment [11] . The best follow-up period for monitoring parasitologic cure has been a topic of discussion [8] . Six weeks is considered the optimal follow-up period for the evaluation of schistosomiasis treatment, as this is the ''parasitologic window'' in which most eggs from previous infections would be excreted and eggs from prepatent infections would not yet have appeared. At the 6-week follow-up in this focus, the parasitologic cure rate obtained by oxamniquine treatment was significantly better than that of praziquantel and, in contrast to praziquantel, highly comparable with what has been observed in other areas [1, 12] .
Prepatent infections may explain in part the difference in cure, as such infections become susceptible to praziquantel treatment 1 week later than they become susceptible to oxamniquine treatment [13] . However, after the randomization procedure, the oxamniquine group still possessed higher intensities of infection and therefore probably maintained even more pre- Egg count reduction in subjects who did not achieve cure after treatment with either praziquantel (n Å 42) or oxamniquine (n Å 15), before and 6 weeks after treatment.
rates or at least cure rates similar to those of the praziquantel cantly better than after 40 mg/kg praziquantel. This observation supports the hypothesis about a Senegalese schistosome strain group. Furthermore, in the focus of Maniema, Zaire, intensities of infection equally high as those in this Senegalese focus were with an increased tolerance to the latter drug. To still be able to design adequate control strategies in the future, further studies encountered [12] . However, in the Zairian focus, cure rates after oxamniquine treatment were inferior to those obtained by should be undertaken to verify this hypothesis, and efforts should be made to understand the underlying mechanisms of praziquantel treatment [12] . An abundance of prepatent infections alone can thus not sufficiently explain the low parasitothis phenomenon. logic cure rates observed after praziquantel treatment in this Senegalese schistosomiasis focus.
The different working mechanisms of praziquantel and ox-
